Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kegan Liyan Oral Solution (克感利咽口服液) is a traditional Chinese medicine (TCM) oral liquid formulation developed by Guangzhou Wanglaoji Pharmaceutical. It is composed of 14 herbal ingredients, including *Lonicera japonica* (honeysuckle), *Scutellaria baicalensis* (scutellaria), *Nepeta tenuifolia* (nepeta), *Gardenia jasminoides* (gardenia), *Forsythia suspensa* (forsythia), *Scrophularia ningpoensis* (scrophularia), *Bombyx batryticatus* (processed with ginger), *Rehmannia glutinosa* (rehmannia), *Belamcanda chinensis*, *Platycodon grandiflorus*, *Mentha haplocalyx*, *Periostracum cicadae*, *Saposhnikovia divaricate*, and *Glycyrrhiza uralensis*. It is traditionally used to clear heat, resolve dampness, and relieve sore throat symptoms associated with wind-heat syndrome, such as in acute pharyngitis, influenza, and mild COVID-19. Guangzhou Wanglaoji Pharmaceutical is conducting Phase III clinical trials in China to evaluate its efficacy and safety for acute pharyngitis (wind-heat syndrome).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kegan Liyan Oral Solution.